VIE/TLR2 (VIE/TLR2)

Vienna Stock Exchange: VIE/TLR2 · EUR

€2.37

-0.01 (-0.4%)· Recorded snapshot

Market cap	346.8M
Revenue (ttm)	829.2M
Net income (ttm)	-141.4M
EPS (ttm)	-€1.24
P/E (forward)	15.6x

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 829.2M
Net income (ttm): -141.4M
EPS (ttm): -€1.24
P/E (forward): 15.6x
Market cap: 346.8M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E15.6

P25 14.3P50 18.7P75 25.4

Trailing P/En/a

P25 20.4P50 26.7P75 39.7

ROE-9.4

P25 4.8P50 10.6P75 20.1

ROIC-3.3

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/TLR2 indicators

Market & fundamental data

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	United States
Country code	AT
Earnings date	2026-10-08
Employees	3,595
Employees change	753
Employees growth	26.5%
Enterprise value	EUR 469.7M
Exchange	Vienna Stock Exchange
Financial currency	USD
Financial report date	2026-08-31
First seen	2026-05-10
Fiscal year end	May
Industry	Drug Manufacturers - Specialty & Generic
Is primary listing	No
ISIN number	US88688T2096
Last earnings date	2026-10-08
Last refreshed	2026-10-30
Last stock split date	2025-12-02
Last stock split type	Reverse
Market cap	EUR 346.8M
Next earnings date	2027-01-08
Price	EUR 2.37
Price currency	EUR
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-29
Symbol	vie/TLR2
Website	https://www.tilray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings yield	-52.26%
EV/EBITDA	27.58x
EV/Sales	0.54x
FCF / EV yield	-21.78%
FCF yield	-29.5%
Forward P/E	15.64x
P/B ratio	0.25x
P/S ratio	0.42x
Price / tangible book value	0.49x
Price/EBITDA ratio	31.74x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	-6.02%
EBITDA margin	1.32%
Gross margin	29.35%
Operating margin	-6.02%
Pretax margin	-13.04%
Profit margin	-17.05%
Profit per employee	EUR -39,330
Revenue per employee	EUR 230,662
ROA	-1.64%
ROA (5Y)	-1.95%
ROCE	-3.06%
ROE	-9.38%
ROE (5Y)	-29.74%
ROIC	-3.29%
ROIC (5Y)	-3.83%
SBC / revenue	4.93%
Tax / revenue	2.19%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth years	1
Gross profit growth	17.88%
Gross profit growth (Q)	34.87%
Gross profit growth 3Y	23.23%
Gross profit growth 5Y	15.22%
Net income growth years	1
Revenue growth	15.93%
Revenue growth (Q)	22.74%
Revenue growth (QoQ)	-8.72%
Revenue growth 10Y	59.51%
Revenue growth 3Y	13.95%
Revenue growth 5Y	11.31%
Revenue growth quarters	5
Revenue growth years	3

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -29.7M
Depreciation and amortization	EUR 63.1M
EBIT	EUR -49.9M
EBITDA	EUR 10.9M
EPS	EUR -1.24
Financing cash flow	EUR 107.7M
Free cash flow	EUR -102.3M
Free cash flow minus SBC	EUR -143.2M
Gross profit	EUR 243.3M
Income taxes	EUR 18.2M
Investing cash flow	EUR -77.1M
Net borrowing	EUR -31.2M
Net cash flow	EUR -40M
Net income	EUR -141.4M
Operating cash flow minus SBC	EUR -113.5M
Operating income	EUR -49.9M
Revenue	EUR 829.2M
Stock-based compensation	EUR 40.9M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	-1.69
Book value per share	EUR 9.72
Debt / EBITDA	19.56
Debt / equity	0.23
Goodwill	EUR 671.8M
Interest coverage	-2.02
Long-term assets	EUR 1.3B
Long-term liabilities	EUR 236.4M
Net cash (debt)	EUR -132.5M
Net cash / market cap	-38.21%
Net debt / EBITDA	12.13
Net debt / equity	0.1
Piotroski F-Score	4
Property, plant and equipment	EUR 632.2M
Shareholders' equity	EUR 1.4B
Tangible book value	EUR 713.4M
Tangible book value per share	EUR 4.96
Total assets	EUR 2B
Total cash	EUR 187.7M
Total debt	EUR 320.2M
Total liabilities	EUR 621M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.44
Current assets	EUR 721.2M
Current liabilities	EUR 384.6M
Current ratio	1.88
Inventory turnover	2.22
Net working capital	EUR 218.8M
Quick ratio	0.95
Working capital	EUR 324.5M
Working capital turnover	2.05

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-26.7%
Shareholder yield	-26.7%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 4.16
1D price change	-0.42%
1M price change	-32.72%
1M total return	-32.72%
1W price change	-11.26%
1W total return	-11.26%
1Y price change	-80.6%
1Y return CAGR	-80.62%
1Y total return	-80.6%
20-day SMA	EUR 2.90
200-day SMA	EUR 4.75
3M price change	-34.03%
3M total return	-34.03%
3Y price change	-85.97%
3Y return CAGR	-48.03%
3Y total return	-85.97%
50-day SMA	EUR 3.40
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 12.64
52-week high date	2025-12-17
52-week low	EUR 2.37
52-week low date	2026-10-29
6M price change	-58.22%
6M total return	-58.22%
All-time high	EUR 31.26
All-time high date	2023-09-12
All-time low	EUR 2.37
All-time low date	2026-10-29
Average true range (ATR)	EUR 0.10
Average volume	0.6
Change from 52-week high	-81.29%
Change from 52-week low	0%
Change from all-time high	-92.43%
Change from all-time low	0%
Change from open	-0.84%
Day's gap	0.42%
High price	EUR 2.42
Low price	EUR 2.37
Monthly RSI	35.35
Open price	EUR 2.39
Position in 52-week range	0%
Previous close	EUR 2.38
Price vs 150-day SMA	-43.08%
Price vs 20-day SMA	-18.34%
Price vs 200-day SMA	-50.24%
Price vs 50-day SMA	-30.44%
Relative volume	2.86
RSI	17.35
Sharpe ratio	-1.71
Sharpe ratio (3Y)	-0.54
Sortino ratio	-2.59
Sortino ratio (3Y)	-0.83
Weekly RSI	26.92
YTD price change	-69.88%
YTD total return	-69.88%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	144.4M
Shares change (QoQ)	15.43%
Shares change (YoY)	26.7%
Shares held by insiders	1.57%
Shares held by institutions	8.49%
Short ratio	5.2 days

Deeper analysis on VIE/TLR2

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/TLR2 report

Is a complete VIE/TLR2 research report available?

No complete published report is available for vie/TLR2 (VIE/TLR2) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/TLR2 (VIE/TLR2)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/TLR2

Valuation

Profitability

Balance sheet

Next earnings

Sector percentile context

All VIE/TLR2 indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/TLR2

Frequently asked questions